vimarsana.com

Latest Breaking News On - நிறுவனம் புதுப்பிப்பு மாநாடு - Page 1 : vimarsana.com

Esperion Therapeutics, inc (ESPR) Q2 2021 Earnings Call Transcript

Operator Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions]. Following the presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to Ben Church, Investor Relations and Corporate Communications at Esperion. Please go ahead, sir. Benjamin Church Head, Corporate Communications & Investor Relations Thank you, operator. Good morning and welcome to Esperion s Second Quarter 2021 Financial Results and Company Update Conference Call. I m Ben Church and I m responsible for Investor Relations and Corporate Communications here at Esperion. I want to remind callers that the information discussed on the call today is covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act. I caution listeners that management will be making forward-looking statements.

Esperion Therapeutics Inc (ESPR) Q1 2021 Earnings Call Transcript

Operator Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions] I would now like to hand the conference over to Ben Church, Investor Relations and Corporate Communications at Esperion. Please go ahead, sir. Benjamin Church Head, Corporate Communications & Investor Relations Thank you, operator. Good afternoon and welcome to Esperion s First Quarter 2021 Financial Results and Company Update Conference Call. I m Ben Church, and I m responsible for Investor Relations and Corporate Communications here at Esperion. With me on today s call are Tim Mayleben, President and Chief Executive Officer; Sheldon Koenig, Chief Operating Officer; and Rick Bartram, Chief Financial Officer. I want to remind callers that the information discussed on the call today is covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act. I caution listeners that management will be making forward-looking statements. Actual results could differ mater

Esperion Therapeutics Inc (ESPR) Q4 2020 Earnings Call Transcript

Esperion Therapeutics Inc (ESPR) Q4 2020 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Esperion Therapeutics Inc (NASDAQ: ESPR) Popular Searches Operator Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions] Please be advised that today s conference call may be recorded. I would now like to hand the conference call over to Ben Church, Investor Relations and Corporate Communications at Esperion. Please go ahead, sir. This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company s SEC filings. Please see our

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.